Wednesday, July 20, 2022 7:19:25 AM
I understand that the company did not officially release TLD, even though their later PRs/filings claim they did. My issue is with why they allowed a third party to dribble part of TLD instead of waiting, as they promised, to make a big show with a journal and a spate of PRs. They are not exactly in a quiet period if they release a PR about a presentation that contains TLD or if they present that same information from NYAS at ASCO or talk to people other than investors about it.
The PR announcing the talk at NYAS and the hints given to people that were broadly circulated here and elsewhere prior to NYAS set up an expectation that they were doing what they promised and instead they did something different. Just as they have been hinting for months now that a journal article is imminent. Remember those posts from MAY about the journal article being out very very soon . . . 2+ months ago? Or Dave Innis supposedly talking about hoping for the ASM by mid-July? It is now mid-July and not only no ASM but no announcement of an ASM (10-30 day notice) and no sign of the journal that will presage that announcement.
I am (and was) fine with waiting on the journal, I am not fine with leading people to believe that you are going to do one thing and instead doing something very harmful to investors. And I find in comical how many people on this board tell me we don't know why they did things the way they did and simultaneously tell me I am wrong about why they did it. I do not have a position on why they did it or whether or not it was a good thing until either they explain why it was done or refuse to explain it. I simply feel that an explanation is required. Why others feel no explanation is required is a mystery to me.
Whatever their reasons, I feel that the way they have handled this SPECIFIC event has hurt the company by driving away potential investors that they will need due to the position they find themselves in on the OTC with no official TLD release. As I mentioned more than a year ago, I think it would be bad for the stock if they were to still be on the OTC when approvals start rolling in. To me, that is the point of the big TLD announcement, to get the share price up enough to get back on an actual exchange. I don't think they can count on another big pre-TLD run up on expectations after losing investors $1 billion in equity last time they head-faked.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM